IBS

Curated by Signal

Developer of saliva-based glucose test for diabetes

Overview

Developer of saliva-based glucose test for diabetes. The company offers Biosensor Platform is a small, printable organic strip revolutionizing portable testing through fingerprint sweat analysis.

Key facts

Headquarters: New York City, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

3 products and services: Sign up to view
Commercial model: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Boston Lighthouse Innovation
Developer of bioinformatics platform for clinical genomics laboratory management
Life Sciences TechnologyCambridge, United States
One Codex
Microbial genomics reference platform for clinical diagnostics
Life Sciences TechnologySan Francisco, United States
Anya
Developer of nutritional products for women health
Life Sciences TechnologyLong Beach, United States

About IBS

What does IBS do?

Developer of saliva-based glucose test for diabetes.

Where is IBS headquartered?

IBS is headquartered in New York City, United States.

Which sector is IBS in?

IBS operates in Life Sciences Technology.

Who are IBS's competitors?

Companies similar to IBS include Boston Lighthouse Innovation, One Codex, and Anya.